India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
ALZHEIMER’S BLOOD TEST AIDS EARLY DETECTION BUT LIMITATIONS Why in the News? A blood test for Alzheimer’s disease biomarkers, already cleared in the U.S. and available in India, can detect biological changes linked to the disease. However, experts caution that it is not a general screening test, particularly for people without symptoms. Science Behind Alzheimer’s …
Read MoreINDIA’S FIRST ALZHEIMER’S DISEASE-MODIFYING THERAPY Why in the News? Drug Launch: Eli Lilly launched donanemab in India under the brand name Lormalzi for Alzheimer’s treatment. First Therapy: It is the first Alzheimer’s disease-modifying therapy commercially launched in India for early-stage patients. High Cost: The treatment costs around ₹91,688 per dose and requires monthly infusions for …
Read MoreGLP-1 Drugs Evolve from Obesity to Alzheimer’s: A Promising Therapeutic Approach Why in the News ? GLP-1-based drugs, initially developed for diabetes and later effective in obesity, are now being explored as a potential therapeutic intervention for Alzheimer’s disease and other neurodegenerative diseases. Research suggests GLP-1 may reduce brain inflammation and improve cognitive function, offering …
Read MoreRARE GENE VARIANT OFFERS HOPE AGAINST ALZHEIMER’S DISEASE THROUGH INFLAMMATION CONTROL Why in the News? New discovery: A rare gene variant, APOE3-R136S, found to delay Alzheimer’s disease by suppressing brain inflammation and modulating the innate immune response, particularly through the regulation of cyclic GMP-AMP synthesis in the central nervous system. Published study: Findings appear in …
Read More
